- CLDX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $28.4 million.
- CLDX has traded 1.2 million shares today.
- CLDX is up 3% today.
- CLDX was down 5.3% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in CLDX with the Ticky from Trade-Ideas. See the FREE profile for CLDX NOW at Trade-Ideas More details on CLDX: Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States. Currently there are 7 analysts that rate Celldex Therapeutics a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Celldex Therapeutics has been 2.1 million shares per day over the past 30 days. Celldex has a market cap of $1.4 billion and is part of the health care sector and drugs industry. The stock has a beta of 3.32 and a short float of 20.9% with 10.44 days to cover. Shares are down 40.9% year-to-date as of the close of trading on Thursday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.